Learn More
PeproTech IL-31 Polyclonal Antibody, PeproTech®, Invitrogen™
Rabbit Polyclonal Antibody
£177.00 - £1468.00
Specifications
| Antigen | IL-31 |
|---|---|
| Concentration | 0.1-1.0 mg/mL |
| Applications | ELISA, Western Blot |
| Classification | Polyclonal |
| Conjugate | Unconjugated |
| Product Code | Brand | Quantity | Price | Quantity & Availability | |||||
|---|---|---|---|---|---|---|---|---|---|
| Product Code | Brand | Quantity | Price | Quantity & Availability | |||||
|
17864873
|
PeproTech
500-P249-50UG |
50 μg |
£177.00
50µg |
Please sign in to purchase this item. Need a web account? Register with us today! | |||||
|
17875583
|
PeproTech
500-P249-100UG |
100 μg |
£228.00
100µg |
Please sign in to purchase this item. Need a web account? Register with us today! | |||||
|
17885503
|
PeproTech
500-P249-1MG |
1 mg |
£1468.00
1mg |
Please sign in to purchase this item. Need a web account? Register with us today! | |||||
Description
AA Sequence of recombinant protein: SHTLPVRLLR PSDDVQKIVE ELQSLSKMLL KDVEEEKGVL VSQNYTLPCL SPDAQPPNNI HSPAIRAYLK TIRQLDNKSV IDEIIEHLDK LIFQDAPETN ISVPTDTHEC KRFILTISQQ FSECMDLALK SLTSGAQQAT T. Preparation: Produced from sera of rabbits immunized with highly pure Recombinant Human IL-31. Anti-Human IL-31-specific antibody was purified by affinity chromatography employing an immobilized Human IL-31 matrix. Sandwich ELISA: To detect Human IL-31 by sandwich ELISA (using 100 μL/well antibody solution) a concentration of 0.5-2.0 μg/mL of this antibody is required. This antigen affinity purified antibody, in conjunction with PeproTech Biotinylated Anti-Human IL-31 (500-P249Bt) as a detection antibody, allows the detection of at least 0.2-0.4 ng/well of Recombinant Human IL-31. Western Blot: To detect Human IL-31 by Western Blot analysis this antibody can be used at a concentration of 0.1-0.2 μg/mL. Used in conjunction with compatible secondary reagents the detection limit for Recombinant Human IL-31 is 1.5-3.0 ng/lane, under either reducing or non-reducing conditions.
Interleukin-31 (IL-31) is a recently discovered T-cell cytokine closely related to IL-6 type cytokines and is preferentially produced by T helper type 2 cells. IL-31 activity is mediated through the ligand-induced oligomerization of a dimeric receptor complex containing IL-31 receptor A and oncostatin M receptor. In response to IL-31 binding, these proteins activate the JAK/STAT and the AKT signaling pathways. RNA levels of IL-31 receptor A and oncostatin M receptor are induced in activated monocytes but are expressed constitutively in epithelial cells. IL-31, when overexpressed in transgenic mice, results in the development of pruritis, alopecia, and skin lesions and in humans may result in atopic dermatitis, suggesting that IL-31 may represent a novel target for antipruritic drug development.Specifications
| IL-31 | |
| ELISA, Western Blot | |
| Unconjugated | |
| Rabbit | |
| Human | |
| Q6EBC2 | |
| 386653 | |
| E.coli-derived Recombinant Human IL-31. | |
| Antigen affinity chromatography | |
| Il31 |
| 0.1-1.0 mg/mL | |
| Polyclonal | |
| Lyophilized | |
| RUO | |
| PBS with no preservative | |
| 1700013B14Rik; IL31; IL-31; ILN; Interleukin; interleukin 31; interleukin-31 | |
| Il31 | |
| Primary | |
| -20°C |
Your input is important to us. Please complete this form to provide feedback related to the content on this product.